Chronic Ischemic Heart Disease
Conditions
Brief summary
Observational, prospective multicentric, national study, evaluating the diagnostic and therapeutic pathways of patient with cronic coronary artery disease followed in Italian cardiology centers.
Detailed description
Coronary heart disease is still highly prevalent in the world, and chronic stable angina is one of the most common clinical presentations of this disease. The objectives of chronic stable angina treatment include the reduction of symptoms, the inhibition or slowing of the progression of the disease, the prevention of associated cardiovascular events such as myocardial infarction, and the possible improvement of survival.The results of COURAGE Study and of meta-analysis of more recent studies demonstrate that patients in optimized medical therapy (OMT) (aspirin, beta-blocker and statin in association with an ACE-inhibitor and strict control of risk factors). ) the percutaneous coronary revascularization procedure (PCI) did not lead to an improvement in the cardiovascular prognosis. These data led the groups in charge of drafting the guidelines to recommend OMT as an initial treatment of stable angina, reserving the revascularization procedure for those patients with symptoms not adequately controlled by medical therapy. It is therefore considered appropriate to plan a registry in patients with stable coronary artery disease that has the ability to describe in the heterogeneity of Italian cardiological centers the current characteristics of these patients, their treatment modalities, adherence to the current guidelines both as regards invasive therapy that the optimized medical, the use and the total cost of the resources needed to manage this pathology, the clinical course one year after entering the register. Consecutive patients discharged (after an ordinary or day hospital admission) or managed as outpatient at Cardiology department participating in the project with a diagnosis of stable coronary artery disease will be included in the register. Enrollment will last 3 months in each center, starting with the first enrolled patient, or up to 50 patients enrolled.
Interventions
OTHERData collection on Stable Ischemic heart disease
No intervention only description of management and treatment
Sponsors
Heart Care Foundation
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients aged \>/= 18 * Patients discharged from hospital or ambulatory visit with a diagnoses of stable heart disease; * Written informed consent
Exclusion criteria
* Acute coronary syndrome within 30 days from enrollment * CCS Angina Class IV * Angina probably not for coronary artery disease
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of patients in medical therapy and that underwent revascularization | Enrollment | Number of patients in medical therapy and that underwent revascularization |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of patient in optimal medical therapy | 12 months Follow-up | Patient treated according to International Guidelines |
| Mortality rate | 12 months Follow-up | Rate of patients died |
| All cause hospitalization rate | 12 months Follow-up | Rate of patients hospitalized |
| Angina recurrence rate | 12 months Follow-up | Rate of patients with angina symtoms |
Countries
Italy
Outcome results
None listed